On the other hand, the role of FOXO1, which is another important nuclear binding partner of β-catenin, in hepatic energy metabolism and metabolic disorders such as non-alcoholic fatty liver disease (NAFLD) and T2D, has been well documented [46,47]. Here, FOXO1 is linked to metabolic disease.